EPOH HS Protocol™

A Structured Path
from Recurrence
to Remission

HS does not recur randomly. It recurs because the internal conditions that create it — inflammatory load, gut dysfunction, hormonal imbalance, immune dysregulation — have not been addressed. The EPOH HS Protocol™ is built around correcting those conditions, in sequence, at the right depth.

Discuss Your Case Explore the Protocol
5 Sequential Phases
Root Cause Correction
0 Herb Names Listed
100% Personalised
300 HS Cases in Remission
Phase 01 Lowering Inflammatory Load

Removing the triggers sustaining internal inflammation before any repair can begin.

Phase 02 Internal Healing & Gut Repair

Correcting gut dysfunction and microbiome imbalance that drives sustained immune activation.

Phase 03 Functional Detox & Immune Balancing

Clearing accumulated inflammatory load and recalibrating immune response patterns.

Phase 04 External Care & Local Reversal

Targeted wound care, scar management, and local tissue correction — done at the right stage.

Phase 05 Sustaining Remission

Building the long-term internal resilience that prevents recurrence from restarting the cycle.

The Core Problem

Why Treatment Fails When It Targets
Only What Is Visible

Most HS patients have already tried several treatments. Antibiotics. Steroids. In some cases, surgery. And yet — the condition returns. Understanding why this happens is the first step toward a different outcome.

Conventional Approaches

What Most Treatments Focus On

  • Suppressing individual flares as they appear
  • Antibiotics to control surface infection — repeatedly
  • Steroids to reduce visible inflammation temporarily
  • Surgery to remove existing lesions or sinus tracts
  • Biologics to dampen immune response broadly
  • No investigation into why lesions form in the first place
The EPOH Approach

What the Protocol Addresses

  • The internal inflammatory environment creating lesions
  • Gut dysfunction sustaining immune dysregulation
  • Hormonal imbalances — particularly in androgen-excess patterns
  • Metabolic and insulin-related drivers of recurrence
  • Lymphatic stagnation in affected regions
  • The recurrence cycle itself — not just individual episodes

"Unless the underlying causes are addressed, the condition may continue to recur despite treatment — regardless of how aggressively individual lesions are managed."

The EPOH HS Protocol™

Five Phases. One Coherent System.

The Protocol is not a collection of treatments. It is a sequenced clinical system — each phase builds the conditions necessary for the next. The order is deliberate. Skipping phases, or beginning at the wrong stage, is why most non-systemic approaches do not hold.

Ayurveda provides the diagnostic lens — Pitta, Vata, and Kapha together explain why HS is not a single-system disease, and why each phase of the Protocol addresses a different layer of this tridoshic imbalance.

Ayurvedic Foundation of the EPOH Protocol™

Protocol PhaseClinical FocusAyurvedic Parallel
Phase 1 — LReduce inflammatory loadPitta pacification · Ama reduction
Phase 2 — IGut & metabolic repairAgni restoration · Srotas healing
Phase 3 — FDetox & immune rebalancingRakta Shodhana · Srotorodha clearance
Phase 4 — EExternal tissue healingDhatu repair · Vrana Ropana
Phase 5 — SSustained remissionRasayana · Ojas strengthening

Before any healing protocol can take effect, the internal environment sustaining inflammation must change. Phase 1 is not about treating HS directly — it is about removing the conditions that keep it active. This means addressing dietary triggers, identifying personal flare drivers, and resetting the metabolic and immune signals that are continuously fuelling the inflammatory cycle.

What this phase addresses
  • Dietary patterns elevating inflammatory signalling
  • Identified lifestyle triggers specific to the patient
  • Thermal, mechanical, and friction-based aggravators
  • Acute flare management without steroid dependency
  • Insulin and blood sugar dysregulation
Why it comes first
  • Internal repair cannot occur in an actively inflamed environment
  • Gut healing requires prior reduction of inflammatory load
  • Without trigger removal, subsequent phases are undermined
  • Patients in active flare respond poorly to deeper systemic correction
  • This phase creates the metabolic space for real healing to begin
Ayurvedic perspective: This phase corresponds to the process of clearing Ama — accumulated metabolic toxins that sustain inflammatory cascades. Without clearing Ama first, any corrective intervention sits on a compromised foundation.

In many HS patients, the gut is not a secondary consideration — it is a central driver. Gut dysfunction creates a condition where the immune system receives a continuous signal of internal threat. This activates and sustains the inflammatory response that eventually expresses through the skin. Correcting this connection is not optional in chronic or recurring HS — it is foundational.

What this phase addresses
  • Intestinal permeability and microbiome dysbiosis
  • Digestive capacity and absorption efficiency
  • Immune signalling originating in the gut lining
  • Metabolic resetting through internal formulations
  • Hormonal processing dysregulation linked to gut health
What changes during this phase
  • Reduced frequency of acute inflammatory episodes
  • Improved metabolic markers in many patients
  • Reduced systemic immune activation signals
  • Improved tolerance to previously aggravating foods
  • Steadier energy levels and hormonal rhythm
Why antibiotic overuse undermines this phase: Repeated antibiotic courses — a common HS management approach — damage the very microbiome this phase is designed to rebuild. The pattern of antibiotic dependency often worsens the internal conditions that create HS, contributing to long-term recurrence rather than preventing it.

Phase 3 is not aggressive detoxification. In HS — particularly in moderate-to-severe presentations — aggressive purging can destabilise an already dysregulated immune system. This phase uses structured, gentle protocols designed to clear accumulated inflammatory load from tissues and channels, while simultaneously recalibrating immune response patterns that have become misfiring or hypersensitive.

What this phase targets
  • Lymphatic congestion in affected anatomical regions
  • Accumulated metabolic byproducts in inflamed tissues
  • Immune hypersensitivity and misfiring response patterns
  • Blood-level inflammatory markers and cytokine activity
  • Channel-level blockage contributing to local lesion formation
What careful sequencing achieves
  • Visible lesion activity reduces progressively
  • Draining sinuses begin to show reduced output
  • Pain intensity and flare frequency diminish
  • Systemic inflammation indicators stabilise
  • The skin microenvironment begins to shift
Clinical note: The depth of detox intervention is calibrated to the patient's Hurley stage and overall systemic burden. A patient in Stage III HS requires a fundamentally different approach here than a Stage I patient — which is why personalised evaluation always precedes treatment.

External care is meaningful only after the internal inflammatory environment has been brought under control. Applied to actively inflamed tissue without internal correction, even sophisticated topical or local interventions are fighting against the body's own sustained immune response. In the EPOH Protocol, Phase 4 arrives when the internal phases have created the biological conditions for local healing to be sustained.

Local interventions this phase includes
  • Wound care protocols appropriate to lesion stage
  • Scar tissue management and fibrosis reduction
  • Pain cycle interruption at the local tissue level
  • Sinus tract management in advanced presentations
  • Lifestyle ergonomics — friction, pressure, and positioning
Why sequence matters here
  • Local interventions on inflamed tissue re-trigger inflammation
  • Scar management is only effective once lesion activity is reduced
  • Without internal correction, topical results are temporary
  • Tissue healing capacity improves significantly after Phase 2 and 3
  • Early local intervention is a common reason for poor long-term outcomes
On surgery: Surgical removal of lesions can be appropriate and sometimes necessary in specific presentations. However, surgery addresses the existing lesion — it does not correct the internal environment that created it. Without systemic correction, new lesions form in adjacent areas. This is why recurrence after surgery is common, and why the Protocol addresses the systemic layer regardless of surgical history.

Reaching remission is not the same as sustaining it. Many patients achieve significant improvement only to experience a relapse months later — often triggered by stress, hormonal shifts, dietary regression, or seasonal changes. Phase 5 is designed specifically to prevent that pattern by strengthening the patient's internal resilience, recalibrating stress-hormone cycles, and establishing routines that support long-term biological stability.

What this phase builds
  • Long-term immune and hormonal stability
  • Seasonal adaptation to prevent cyclical flares
  • Stress–hormone cycle regulation
  • Lifestyle integration — travel, work, relationships, fitness
  • Early-warning pattern recognition for pre-flare signals
What remission in HS actually looks like
  • Significantly reduced lesion frequency and severity
  • Existing lesions healing rather than expanding
  • Ability to manage triggers without flares
  • Improved quality of life — social, physical, psychological
  • Reduced dependence on symptomatic interventions
Honest framing: Remission in HS does not always mean complete absence of any lesion. It means the disease no longer drives the patient's daily life — flares are less frequent, less severe, and the recovery between episodes is faster. For many long-standing cases, this is a clinically meaningful and achievable outcome.
The EPOH HS Protocol™ — five-phase flow from inflammatory load reduction to sustained remission

The EPOH HS Protocol™ — five-phase flow from inflammatory load reduction to sustained remission

Personalised Ayurvedic Formulations

Why Every Formulation in This Protocol Is Different

There is no single formulation for HS. The condition varies by patient — by hormonal pattern, gut status, disease stage, and metabolic profile. What is described here represents the functional categories of formulation used across the protocol. The specific composition for each patient is determined through individual evaluation, not pre-set protocols.

Inflammatory Load Reduction

Detox & Blood Purification Formula

Reduces the accumulated toxin load circulating in the bloodstream — the sustained internal trigger for repeated lesion formation. This formulation targets the blood-level inflammatory burden that conventional treatment rarely addresses.

Gut & Metabolic Correction

Gut Restoration Formula

Supports microbiome correction, improves intestinal lining integrity, and restores digestive capacity. This formulation interrupts the gut–skin inflammatory axis that is active in most chronic HS presentations.

Hormonal Stabilisation

Hormonal Balance Support

Particularly relevant in female patients with androgen excess or PCOS-linked HS. This formulation targets the endocrine imbalances that drive cyclical flares and impair healing — addressing a layer that most dermatological protocols miss entirely.

Tissue Healing

Skin & Tissue Repair Blend

Promotes structural healing of nodules, sinus tracts, and scarred tissue. Used in Phase 4, when internal inflammation has been adequately reduced and the tissue is ready to respond to repair-oriented intervention.

Immune Resilience

Immune Balancing Formula

Recalibrates rather than suppresses. This formulation reduces immune hypersensitivity while strengthening the body's appropriate defensive capacity — moving away from the misfiring immune response that sustains HS activity.

Long-Term Prevention

Recurrence Prevention Rasayana

Used in Phase 5 to build systemic resilience. This category of formulation supports long-term remission by strengthening the body's capacity to handle the internal and external triggers that previously led to recurrence.

No specific herbs are listed here intentionally. Personalised formulations are determined through clinical evaluation — not prescribed from a fixed protocol.

Clinical Patterns

Seven Reasons HS Patients Don't Improve — Despite Treatment

These are not failures of motivation or effort. They are patterns seen repeatedly in patients who have been through multiple treatment cycles without lasting relief. Each represents a clinical error — often systematic — that any new approach must correct.

01

Misdiagnosis or Delayed Diagnosis

HS is misdiagnosed as folliculitis, furunculosis, or simple boils — sometimes for a decade. During this time, lesions progress and the internal inflammatory burden deepens, making later correction more difficult.

02

Treating the Wrong Target

Treating each lesion as a separate event — rather than as an expression of a continuous systemic process — ensures that new lesions will keep forming. The target must be the internal environment, not the visible output.

03

Diet Mismatch

Diet is not a peripheral consideration in HS. Certain patterns of eating directly elevate the internal inflammatory load. Continuing to eat in ways that sustain inflammation undermines every other treatment being applied simultaneously.

04

Aggressive Intervention at the Wrong Stage

Aggressive detox or deep systemic intervention applied to a patient in active flare, or before the gut has been stabilised, can worsen immune dysregulation. Sequencing is clinical intelligence — not just a preference.

05

Ignoring Systemic Inflammation

The blood-level inflammatory environment in HS is often significantly elevated — even between visible flares. Addressing only the skin while this systemic inflammation continues means the condition always has the internal fuel it needs.

06

Poor Wound Management Protocols

Incorrect wound care — particularly in draining sinuses or post-surgical sites — can introduce secondary infection, delay healing, and generate new inflammatory signals that feed the overall cycle.

07

Psychological Burnout Left Unaddressed

Stress hormones directly affect immune function and inflammatory signalling. HS patients who have lived with the condition for years often carry a level of chronic psychological stress that actively worsens the biological pattern. This is not secondary — it is part of the clinical picture.

What to Expect

What Changes — and When — During the Protocol

This is not a promise of a specific timeline. HS progression and recovery are individual — influenced by disease stage, duration, systemic burden, and patient-specific factors. What follows is the clinical pattern most commonly observed across phases.

Early Phase (1–2)

Internal Environment Begins to Shift

Flare frequency may not drop immediately — but flare intensity often does. Gut symptoms improve. Energy stabilises. Hormonal patterns begin to normalise. This is the phase where the inflammatory foundation is being dismantled.

Middle Phase (2–3)

Lesion Activity Reduces Progressively

Existing lesions begin healing rather than expanding. New lesion formation slows. Draining sinuses show reduced output. Scar tissue softens in some patients. The skin's local environment responds to the internal correction underway.

Later Phase (4–5)

Remission Becomes Sustainable

Lesion-free intervals lengthen. Remaining activity becomes manageable. The patient is able to maintain remission without ongoing dependence on suppressive interventions. Sustained remission — not just temporary relief.

Honest framing: Advanced-stage HS — particularly with established sinus tracts or extensive fibrosis — requires more time and may not fully reverse all structural changes. The goal in these cases is meaningful reduction in activity, improved quality of life, and prevention of further progression — not the same as early-stage reversal.

"When a condition keeps recurring, it usually follows an underlying pattern that needs to be understood and addressed — not suppressed."

Patient Suitability

Who This Protocol Is For — and Who It Is Not

This is a structured, time-intensive, personalised clinical process. It requires patient commitment and realistic expectations. Not every patient in every situation is an appropriate candidate.

The Protocol Is Appropriate If

  • HS has been recurring despite antibiotics, steroids, or surgery
  • You are seeking root-cause correction rather than ongoing symptom management
  • Your HS is connected to hormonal patterns — PCOS, androgen excess, or cyclical flares
  • You have gut-related symptoms alongside skin involvement
  • You are in Hurley Stage I, II, or early Stage III and want to prevent further progression
  • You are willing to make guided lifestyle and dietary changes as part of treatment
  • You have had surgery but continue to develop new lesions
  • You want to reduce or eventually end dependence on biologics or antibiotics

This May Not Be Appropriate If

  • You are looking for a quick or guaranteed fix — HS reversal requires time
  • Acute surgical intervention is immediately necessary (emergency presentations)
  • You are unwilling to modify diet or lifestyle as part of the process
  • You expect complete symptom absence without a sustained treatment commitment
  • Your situation requires emergency wound management outside a clinical setting

The best way to determine suitability is through a structured evaluation — a clinical conversation about your specific pattern of HS, history, and current situation. This evaluation is not a sales process. It is an honest assessment of whether this approach matches your condition.

The Clinician

Built from Clinical Observation — Not Textbook Alone

Dr. Adil Moulanchikkal, BAMS, developed the EPOH HS Protocol™ not through academic study of HS alone, but through years of working with patients who had already exhausted standard options.

Many patients who consult EPOH come after years of recurrence — having tried antibiotics, steroids, biologics, and in many cases, surgery. Their outcomes did not match their effort. What they consistently lacked was a framework that addressed the condition as a systemic, progressive process — not as a series of disconnected episodes.

The protocol emerged from observing patterns in these patients — what made some improve while others stagnated, what the early signals of systemic correction looked like, and what the stages of genuine remission involved. This clinical intelligence is what the EPOH HS Protocol™ encodes.

"The EPOH HS Protocol™ is a philosophy of healing rooted in Ayurveda and strengthened by modern medical insight. The goal is not quick fixes, but steadier recovery, fewer flare-ups, and a better quality of life."

— Dr. Adil Moulanchikkal, BAMS
BAMS Ayurvedic Physician
HS Clinical Specialty
5 Phase Protocol
Root Cause Approach
Learn More About Dr. Adil →
Begin Here

If It Keeps Coming Back,
the Cause Has Not Been Addressed

A structured evaluation is the first step toward understanding what is actually driving your HS — and whether this protocol is appropriate for your situation.
Speak with EPOH on WhatsApp Begin Evaluation

EPOH · Dr. Adil Moulanchikkal, BAMS · +91 88847 22246 · Personalised evaluation required before treatment commences

Go Deeper

Clinical Articles Related to the Protocol

All Articles